跳至主要内容
临床试验/NCT07265895
NCT07265895尚未招募不适用

Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations, Monocentric Retrospective Observational Study

IRCCS San Raffaele1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2026年1月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
200
试验地点
1
主要终点
Best-corrected Visual Acuity

研究概览

简要总结

Inherited Retinal Diseases (IRDs) are a heterogeneous group of genetically based degenerative retinal disorders, representing a major cause of visual impairment and blindness in working-age adults. Despite the approval of the first gene therapy for RPE65-related IRD (voretigene neparvovec) in 2017, most IRDs remain untreatable, though many gene therapies are in development. Effective trial design and therapy development require a deep understanding of disease natural history and genotype-phenotype correlations. Over 270 IRD-associated genes are known (e.g., ABCA4, USH2A, RPGR, PRPH2, BEST1), each linked to distinct phenotypes and clinical progression. This retrospective study analyzes clinical, functional, and imaging data (Optical Coherence Tomography, Fundus Autofluorescence, Microperimetry) from a large, genetically characterized IRD cohort at the IRCCS Ospedale San Raffaele up to December 31, 2025. The aims are to describe natural history, define genotype-phenotype relationships, and identify structural and functional outcome measures useful for future clinical trial endpoints, supporting personalized prognosis and trial design.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Participant completed at least one ophthalmological and retinal imaging examination at our center.
  • Clinically diagnosed with IRD, as per familiy history, clinical signs or symptoms, retinal imaging findings.
  • Definitive genetic diagnosis of IRD with adequate molecular test

排除标准

  • Affected by other retinal or optic nerve conditions potentially affecting analyses (diabetic retinopathy, glaucoma).
  • History of retinotoxic medications (i.e., hydroxychloroquine, pentosan polysulfate sodium, tamoxifen, ritonavir, didanosine, MEK inhibitors) intake.
  • Unclear genetic diagnosis.
  • Incomplete or inadequate ophthalmological and imaging tests.

结局指标

主要结局

Best-corrected Visual Acuity

时间窗: through study completion, an average of 1 year

Measured on measured Early Treatment Diabetic Retinopathy Study (ETDRS) charts and recorded in logMAR units

Macular threshold sensitivity

时间窗: through study completion, an average of 1 year

Measured in decibels using fundus- tracked MP (e.g., MAIA device) across a standard grid of 68 central loci under standardized mesopic conditions. Sensitivity deviation from age-matched normative values will also be computed

Total Macular volume

时间窗: through study completion, an average of 1 year

Measured in mm3 on OCT scans

Centra Subfield Thickness

时间窗: through study completion, an average of 1 year

Measured in micron on OCT scans

Preserved Ellipsoid zone area

时间窗: through study completion, an average of 1 year

Measured in mm2 on OCT scans

Foveal Outer Nuclear Layer thickness

时间窗: through study completion, an average of 1 year

Measured in microns on OCT scans

Ellipsoid zone loss area

时间窗: through study completion, an average of 1 year

Measured in mm2 on OCT scans

Hyperautofluorescent (Robson- Holder) ring area

时间窗: through study completion, an average of 1 year

Measured in mm2 on FAF images

Dereased Autofluorescence area

时间窗: through study completion, an average of 1 year

Measured in mm2 on Fundus autofluorescence images

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maurizio Battaglia Parodi

Associate Professor

IRCCS San Raffaele

研究点 (1)

Loading locations...

相似试验